2. Who needs to help in tackling
antibiotic resistance?
Antibiotic resistance is a complex issue that has arisen due
to multiple, interlinked factors. Therefore, coordinated rather
than isolated interventions are necessary to combat this
problem5
Coordinated action between the following groups is required:
Health care providers1
Patients and the general public1
Governments and industries1
3. Key problems
Prevalence of deadly infectious diseases
Overuse and misuse of antibiotics by patients
Misdiagnosis of infections and incorrect prescription
Misuse of antibiotics in animals
Lack of tools to monitor antibiotic resistance
Lack of coordination between stakeholders
4. Retrieved from: CDC Features - Mission Critical: Preventing Antibiotic Resistance [Internet]. Cdc.gov. 2016
[cited 7 April 2016]. Available from: http://www.cdc.gov/features/antibioticresistance/
5. Usage of antibiotics
Misuse of antibiotics contributes to resistance
This includes overuse of antibiotics, not finishing a course of
antibiotics, sharing antibiotics, using antibiotics in animals, and so
on1,4,5
Patients should finish the prescribed course of antibiotics even
when they already ‘feel better’1
Antibiotics should only be used when prescribed by a doctor1,5, and
over-the-counter sales of antibiotics need to be closely monitored to
prevent misuse
People should not share antibiotics with others or use leftover
prescriptions1
The use of antibiotics in the agricultural industry needs to be
managed to prevent acceleration of antibiotic resistance4
6. Infection control
The prevalence of infections is often exacerbated by or caused by
unsanitary living conditions, lack of personal and interpersonal
hygiene, and lack of infection control within shared facilities
Prevention is better than cure -> preventing infections in the first
place is more efficient than having to deal with the costs of treating
them
Prevention includes:
- Better hygiene practices
- Avoiding close contact with sick people
- More clean water access
- better infection control in health care facilities
- immunisation programs for infants and children -> herd immunity
- tools to track resistance
7. Diagnosis and prescription
Diagnostic uncertainty is a key factor in antibiotic misuse and
overuse, and thus antibiotic selection pressure and resistance2
Doctors often do not have quick enough diagnostic tests, and are
forced to start treating severely ill patients with broad-spectrum
antibiotics before lab results arrive3
Some diagnoses are incorrect and result in incorrect antibiotic
prescription1,2
Inappropriate or unnecessary antibiotic prescription contributes to
resistance
Quicker and more accurate diagnostic tests, using improved
information technology and microbiological progress can lead to
improved antibiotic selection, dosing and treatment duration4
More accurate prescription is also necessary to ensure that the right
antibiotics are being taken1
8. Policymakers and industry
Governments need to support and promote different campaigns,
policies, interventions and regulations to tackle antibiotic resistance1:
Educational campaigns and available information aimed at changing
attitudes towards antibiotic prescription and usage, to optimise drug
use4
Regulating appropriate use of drugs and medicine1
Encouraging and rewarding research and development into new
tools to track and monitor antibiotic resistance and its causes, as well
as to better diagnose infection1 and treat disease5
Encouraging infection control across sectors5, not just in health care
facilities
Data sharing and cooperation between stakeholders, for a
coordinated response to resistance and consistent worldwide control
measures1,4,5. This will prevent inconsistent action between taken by
countries to tackle the issue
9. Retrieved from: ReAct - ANTIBIOTIC RESISTANCE – A CALL FOR GLOBAL ACTION [Internet]. Reactgroup.org.
2016 [cited 7 April 2016]. Available from: http://www.reactgroup.org/news/354/18.html
10. International cooperation
The World Health Organisation (WHO) is actively
involved in coordinating global policies and supporting
member states in the fight against antibiotic resistance5
It is also bringing stakeholders together to decide on a
common plan to tackle the problem of resistance, and
strengthening national stewardship5
Active encouragement of innovation, research and
development in relevant industries is also taking
place1,5
11. US plan against resistance
The White House has released a ‘National Action plan for
Combating Antibiotic-Resistant Bacteria’3
This calls for consistent action across federal agencies and
sets five main goals for reducing resistance and antibiotic
misuse3:
1- Preventing the spread of antibiotic resistance
2- Strengthening surveillance efforts
3- Advancing diagnostic testing
4- Accelerating the development of new antibiotics
5- Improving global collaboration
This is another example of a large scale response towards
antibiotic resistance
12. Therefore, there are steps that can be taken to remedy
the problem at hand
It requires a cooperative and consistent response
between people, industries, governments and countries
Hopefully we will see these steps being taken, and the
world will not have to deal with the consequences of a
post-antibiotic era
13. Retrieved from: ReAct - ReAct WORLD HEALTH DAY Activitites [Internet]. Reactgroup.org. 2016 [cited 7 April
2016]. Available from: http://www.reactgroup.org/what-we-do/react-world-health-day.html
14. References
1. WHO | WHO’s first global report on antibiotic resistance reveals serious,
worldwide threat to public health [Internet]. Who.int. 2016 [cited 4 April 2016].
Available from: http://www.who.int/mediacentre/news/releases/2014/amr-
report/en/
2. Nuermberger E, Bishai W. Antibiotic Resistance in Streptococcus pneumoniae:
What Does the Future Hold?. Clinical Infectious Diseases. 2004;38(Supplement
4):S363-S371.
3. Krisberg K. US charting new path to combat growing antibiotic resistance: New
action plan coordinates response. The Nation's Health [Internet]. 2016 [cited 7
April 2016];45(4):1-14. Available from:
http://thenationshealth.aphapublications.org/content/45/4/1.3.full
4. Harbarth S, Samore M. Antimicrobial Resistance Determinants and Future
Control. Emerg Infect Dis. 2005;11(6):794-801.
5. Antimicrobial resistance [Internet]. World Health Organization. 2016 [cited 4 April
2016]. Available from: http://www.who.int/mediacentre/factsheets/fs194/en/